Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes

Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes

Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small-cell lung cancer (NSCLC) is the most common type accounting for 84% of all lung cancers. Paclitaxel (PAC) is a widely used drug in the treatment of a broad spectrum of human cancers, including lung. While efficacious, PAC...

Full description

Bibliographic Details
Main Authors: Raghuram Kandimalla, Farrukh Aqil, Sara S. Alhakeem, Jeyaprakash Jeyabalan, Neha Tyagi, Ashish Agrawal, Jun Yan, Wendy Spencer, Subbarao Bondada, Ramesh C. Gupta
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
colostrum exosomes
paclitaxel
drug delivery
lung cancer
immunotoxicity assessment
Online Access:https://www.mdpi.com/2072-6694/13/15/3700

Internet

https://www.mdpi.com/2072-6694/13/15/3700

Similar Items